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Background: Candida spp. and Aspergillus spp. are responsible
for the vast majority of invasive fungal infections (IFI); however,
unusual fungal species may be involved, especially in immuno-
comrpomised hosts. Hereby, we report series of 7 cases caused by
unusual fungi.
Methods & Materials: Cases of IFI due to rare fungal species
were analysed to describe clinical characteristics and outcomes.
Retrospective cross-sectional studies on fungaemia and invasive
aspergillosis were performed in 2005 – 2012 and cases of IFI due
to unusual species with fatal outcome were included in this case-
series report.
Results: We have identiﬁed 7 fatal cases of IFI caused by
Hansenula polymorpha, Cryptococcus neoformans (in immunocom-
petent host),Candida veronae (Trichosporon veronae, syn.C. terebra),
C. inconspicua, Geotrichum capitatutm, Mucor circinelloides, Tri-
chosporon sp. Average age of case patients was 53 years (SD 29),
most of them were males (4; 57,13%), were hospitalized at inten-
sive care unit (4; 57,13%), were immunocompromised (4; 57,13%),
suffered from sepsis (5; 71,43%), and had inserted central venous
catheter (7; 100%). Five patients had bloodstream infections, one
had meningitis (Cryptococcus) and two others had invasive pul-
monary infection. Median duration of therapy was 8 days (IQR
2-28), was performed exclusively with azoles and in 4 cases
(57,13%) was breakthrough. Median time from diagnosis to death
was 9 days (IQR 3-39).
Conclusion: We did not ﬁnd any characteristic clinical fea-
ture or risk factor associated with unusual fungal IFI. However,
with increasing amount of immunocompromised hosts, number of
unusual fungal species included in IFImay increase. Their diagnosis
and treatment can be challenging, especially in cases with intrinsic
resistance, therefore new antifungal drugs have to be included in
therapy.
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Risk factors, species distribution and
susceptibility of candidemia in the Philippines
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Background: The incidence of Candida bloodstream infection
has increased over the past years due to advances in medical tech-
nology. In the Philippines, data on candidemia and susceptibility
patterns are outdated and scarce.
Methods & Materials: This is a prospective analysis of can-
didemia at Philippine General Hospital (PGH), a government
tertiary general hospital and at the National Kidney and Transplant
Institute (NKTI), a government specialtyhospital fromJanuary2012
to December 2012. Candidablood isolateswere sent to Changi Gen-
eral Hospital, Singapore and were subcultured on chromogenic
Candida media. Discordant species were further identiﬁed by phe-
notypic identiﬁcation (ID-YST, Vitek, BioMérieux) and morphology
on cornmeal agar. Antifungal susceptibility testing was performed
using SensititreYeastOne Y10 plates. Minimum inhibitory concen-
trations were read following 24hours incubation, and antifungal
susceptibilities were interpreted using CLSI breakpoints (M27-S4,
2012) as susceptible (S), susceptible dose-dependent (S-DD) and
resistant (R).
Results: Thirty nine candidemia cases with isolates were
reviewed. Nine patientswere from the pediatric group and 30were
adults. The top 3 underlying conditionswere cancer (28.2%), neuro-
logicdisease (20.5%) andboth solid tumorand renal disease (17.9%).
The most common risk factors were orotracheal intubation (33%)
and intraabdominal surgery (33%). Candida tropicalis (35.9%) was
the most prevalent species followed by C. parapsilosis (30.8%) and
C. albicans (28.2%). Majority of the isolates were susceptible to ﬂu-
conazole. The most frequent treatment regimen was ﬂuconazole
monotherapy (43.6%). Overallmortalitywas35.9%: 11out 30 adults
and 3 out of 9 pediatric patients.
Conclusion: This is the ﬁrst description of candidemia in the
Philippines which provides information on species distribution,
antifungal susceptibility pattern and on the clinical features and
outcomes among patients with candidemia. Candida tropicalis was
themost common species isolated. Low resistance rates to ﬂucona-
zole indicate that it may still be utilized as the ﬁrst line drug for
candidemia.
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